| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $577.1M | +23.2% |
| Cost of Revenue | $307.2M | +52.3% |
| R&D Expense | $93.8M | +25.9% |
| SG&A Expense | $81.4M | +25.6% |
| Operating Income | -$112.8M | -39.1% |
| Pre-tax Income | -$135.6M | -42.8% |
| Income Tax | -$5.3M | +94.5% |
| Net Income | -$130.3M | — |
| EPS (Basic) | -$0.98 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $326.3M | +41.6% |
| Accounts Receivable | $976.5M | +5.3% |
| Current Assets | $1.33B | +12.6% |
| Total Assets | $2.71B | -0.0% |
| Current Liabilities | $1.13B | +9.3% |
| Long-term Debt | $754.6M | -0.5% |
| Total Liabilities | $1.92B | +4.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $192.6M | +52.1% |
| Capital Expenditures | $30.8M | +74.1% |
| Investing Cash Flow | -$65.2M | +90.6% |
| Financing Cash Flow | -$30.2M | -104.4% |
| Free Cash Flow | $161.7M | +48.5% |
| — |
| EPS (Diluted) | -$0.98 | — |
| Stockholders' Equity |
| $791.3M |
| -10.2% |